NUSCA, ANNUNZIATA
 Distribuzione geografica
Continente #
AS - Asia 4.865
NA - Nord America 897
EU - Europa 506
OC - Oceania 33
AF - Africa 9
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.318
Nazione #
SG - Singapore 4.333
US - Stati Uniti d'America 871
CN - Cina 337
IT - Italia 148
HK - Hong Kong 137
DE - Germania 75
GB - Regno Unito 74
NL - Olanda 54
EE - Estonia 46
CZ - Repubblica Ceca 42
AU - Australia 33
IN - India 21
CA - Canada 18
FI - Finlandia 15
FR - Francia 11
VN - Vietnam 9
BR - Brasile 7
MX - Messico 6
SE - Svezia 6
ZA - Sudafrica 6
ES - Italia 5
JP - Giappone 5
TR - Turchia 5
AT - Austria 4
ID - Indonesia 4
PL - Polonia 4
RO - Romania 4
UA - Ucraina 4
CH - Svizzera 3
IR - Iran 3
MA - Marocco 3
PK - Pakistan 3
TW - Taiwan 3
LT - Lituania 2
LU - Lussemburgo 2
NO - Norvegia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BE - Belgio 1
DO - Repubblica Dominicana 1
GE - Georgia 1
IE - Irlanda 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
NI - Nicaragua 1
RS - Serbia 1
RU - Federazione Russa 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.318
Città #
Ashburn 416
Singapore 141
Hefei 138
Hong Kong 134
Boardman 88
Rome 80
Beijing 69
London 56
Dallas 55
Tallinn 45
Amsterdam 40
Munich 37
Shanghai 37
Council Bluffs 36
Brno 31
Los Angeles 29
Perth 20
San Francisco 20
Seattle 14
Washington 14
Santa Clara 11
West Jordan 10
Brooklyn 9
Olomouc 9
Bengaluru 8
Helsinki 7
Milan 7
Turku 7
Hanover 6
Jinan 6
Pune 6
São Paulo 6
The Dalles 6
Xi'an 6
Bologna 5
Montreal 5
Tokyo 5
Zhengzhou 5
Chennai 4
Chicago 4
Guangzhou 4
Melbourne 4
New York 4
Nuremberg 4
San Jose 4
Târgu Mureş 4
Aubin Grove 3
Borås 3
Boston 3
Casablanca 3
Conroe 3
Frankfurt am Main 3
Johannesburg 3
Qingdao 3
Seichamps 3
Stockholm 3
Stuttgart 3
Taipei 3
Aberdeen 2
Ankara 2
Atlanta 2
Aversa 2
Basel 2
Calgary 2
Canberra 2
Castagnole 2
Central 2
Centurion 2
Ciampino 2
Durham 2
Florence 2
Gold Coast 2
Hamar 2
Hilo 2
Ho Chi Minh City 2
Krakow 2
Liaocheng 2
Louisville 2
Luxembourg 2
Mainz 2
Mexico City 2
North Bergen 2
Oklahoma City 2
Palermo 2
Quận Ninh Kiều 2
Santiago De Compostela 2
Shenyang 2
Shijiazhuang 2
Sona 2
Springfield 2
Suzhou 2
Thrissur 2
Toronto 2
Vienna 2
Warsaw 2
Xiamen 2
Xiangtan 2
Zhoukou 2
Adelaide 1
Agawam 1
Totale 1.774
Nome #
Circadian variations of platelet reactivity on clopidogrel in patients treated with elective percutaneous coronary intervention 409
Contrast-induced Acute Kidney Injury in Diabetic Patients and SGLT-2 Inhibitors: A Preventive Opportunity or Promoting Element? 210
Characterization of inflammatory profile by breath analysis in chronic coronary syndromes 202
Leptin as predictor of cardiovascular events and high platelet reactivity in patients undergoing percutaneous coronary intervention 200
Designing the Optimal Procedure: Role of CT Scan in the Planning of Transcatheter Structural Heart Interventions 200
Takotsubo Syndrome and Coronary Artery Disease: Which Came First-The Chicken or the Egg? 198
Changes of the Coronary Arteries and Cardiac Microvasculature With Aging: Implications for Translational Research and Clinical Practice 197
[The hybrid strategy for complete myocardial revascularization in the frail elderly patient]. 194
Prediction of type 4a myocardial infarction with the angiography-derived hemodynamic (ADDED) index 193
Current Applications and New Perspectives in Optical Coherence Tomography (OCT) Coronary Atherosclerotic Plaque Assessment: From PCI Optimization to Pharmacological Treatment Guidance 191
Carcinoid Pulmonary Valve Stenosis: Multimodality Imaging and Transcatheter Valve Implant With Prestenting Technique 187
3D transesophageal echocardiographic assessment of acute reverse remodeling of the tricuspid annulus after transcatheter edge-to-edge repair 185
Emerging from the Darkness. Sudden Cardiac Death in Cardiac Amyloidosis 185
Coronary Chronic Total Occlusion Revascularization: When, Who and How? 183
Dexamethasone-eluting stents attenuate endothelial activation in patients with unstable coronary syndromes 183
Antithrombotic treatment for valve prostheses: Which drug, which dose, and when? 175
Dissecting intramyocardial hematoma masquerading as a pseudoaneurysm of left ventricular free wall: an unusual case of myocardial rupture 174
Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data 166
Current management and prognosis of patients with recurrent myocardial infarction 163
Relationship Between the Completeness of Revascularization and Myocardial Injury in Patients Treated With Percutaneous Coronary Intervention 152
Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease 140
Beyond the Calcium Score: What Additional Information from a CT Scan Can Assist in Cardiovascular Risk Assessment? 95
Correction to: The Role of Angiogenesis and Arteriogenesis in Myocardial Infarction and Coronary Revascularization 92
Prediction of 5-Year Mortality in Patients with Chronic Coronary Syndrome Treated with Elective Percutaneous Coronary Intervention: Role of the ACEF Score 92
Combined procedure of transcatheter aortic valve replacement and coronary intravascular lithotripsy 91
Impact of oral anticoagulant regimens on occurrence of contrast-induced nephropathy in patients undergoing coronary angioplasty 91
Arrhythmias after COVID-19 Vaccination: Have We Left All Stones Unturned? 90
Correlation between glycemic variability assessed by CGM and short-term outcome in patients undergoing percutaneous coronary intervention 88
Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention 84
Glycemic variability in the development of cardiovascular complications in diabetes 84
Integrating platelet reactivity in the age, creatinine and ejection fraction score to predict clinical outcomes following percutaneous coronary intervention in patients with chronic coronary syndrome: the PR-ACEF score 83
Impact of burden and distribution of aortic valve calcification on the hemodynamic performance and procedural outcomes of a self-expanding, intra-annular transcatheter aortic valve system 82
Relation of Platelet Indexes to Platelet Reactivity and Periprocedural Myocardial Infarction in Patients Who Underwent Percutaneous Coronary Angioplasty 82
Incidence, diagnosis, and prognosis of myocarditis: does gender matter? 81
Fractional Flow Reserve-Guided Coronary Revascularization: Evidence from Randomized and Non-Randomized Studies 79
Invasive Assessment of Coronary Microvascular Function 76
Impact of Mediterranean diet on metabolic and inflammatory status of patients with polyvascular atherosclerotic disease 71
The Spectrum of Coronary Artery Disease in Elite Endurance Athletes-A Long-Standing Debate: State-of-the-Art Review 68
Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study 66
Classification of Aortic Stenosis Patients via ECG-Independent Multi-Site Measurements of Cardiac-Induced Accelerations and Angular Velocities at the Skin Level 59
In Stent Neo-Atherosclerosis: Pathophysiology, Clinical Implications, Prevention, and Therapeutic Approaches 46
Instantaneous wave-free ratio-guided revascularization of non-culprit lesion in patients with ST-segment elevation myocardial infarction and multivessel coronary disease: design and rationale of the WAVE Registry 41
Eosinophilic Myocarditis: From Bench to Bedside 40
The Pivotal Role of Invasive Functional Assessment in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA) 38
The Role of Angiogenesis and Arteriogenesis in Myocardial Infarction and Coronary Revascularization 32
Usefulness of Adding Pre-procedural Glycemia to the Mehran Score to Enhance Its Ability to Predict Contrast-induced Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention Development and Validation of a Predictive Model 29
Tricuspid Valve Geometrical Changes in Patients with Functional Tricuspid Regurgitation: Insights from a CT Scan Analysis Focusing on Commissures 28
Effects of Finerenone on Cardiovascular and Chronic Kidney Diseases: A New Weapon against Cardiorenal Morbidity and Mortality-A Comprehensive Review 28
Indirect respiratory monitoring via single-lead wearable ECG: Influence of motion artifacts and devices on respiratory rate estimations 28
Who is the next for aortic valve implantation? Present and future indications 28
The butterfly effect: Restoring the tricuspid coaptation after clipping the antero-septal commissure 26
Prevalence and clinical impact of high platelet reactivity in patients with chronic kidney disease treated with percutaneous coronary intervention: An updated systematic review and meta-analysis 26
Percutaneous Repair of Atrial Functional Tricuspid Regurgitation in Cardiac Amyloidosis: Combining Linear With Lateral Thinking 26
Platelet Effects of Anti-diabetic Therapies: New Perspectives in the Management of Patients with Diabetes and Cardiovascular Disease 26
SGLT-2 Inhibitors on Top of Current Pharmacological Treatments for Heart Failure: A Comparative Review on Outcomes and Cost Effectiveness 24
Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention 24
Ranolazine Improves Glycemic Variability and Endothelial Function in Patients with Diabetes and Chronic Coronary Syndromes: Results from an Experimental Study 23
Early prediction of contrast-induced acute kidney injury by a "bedside" assessment of Neutrophil Gelatinase-Associated Lipocalin during elective percutaneous coronary interventions 23
Novel Antidiabetic Agents and Their Effects on Lipid Profile: A Single Shot for Several Cardiovascular Targets 22
Functional Mitral and Tricuspid Regurgitation across the Whole Spectrum of Left Ventricular Ejection Fraction: Recognizing the Elephant in the Room of Heart Failure 21
Periprocedural myocardial infarction after percutaneous coronary intervention and long-term mortality: a meta-analysis 21
Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy 21
Protection from procedural myocardial injury by pre-treatment with atorvastatin is associated with lower expression of adhesion molecules after percutaneous coronary intervention 21
Novel Computed Tomography Variables for Assessing Tricuspid Valve Morphology: Results from the TRIMA (Tricuspid Regurgitation IMAging) Study 17
Rethinking weight loss treatments as cardiovascular medicine in obesity, a comprehensive review 16
Role of polypill in cardiovascular prevention and treatment 15
Double anterograde/retrograde approach for embolization of pulmonary arteriovenous malformation presenting with acute respiratory failure 12
Single-territory incomplete surgical revascularization improves regional wall motion of remote ventricular areas: results from a propensity-matched study. 12
Statin pretreatment and risk of in-hospital atrial fibrillation among patients undergoing cardiac surgery: a collaborative meta-analysis of 11 randomized controlled trials. 11
Totale 6.366
Categoria #
all - tutte 25.835
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.835


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202262 0 0 2 0 2 0 0 0 0 0 9 49
2022/202394 2 1 16 11 13 2 0 2 1 0 46 0
2023/2024641 1 27 31 31 21 97 51 272 20 42 10 38
2024/20255.134 84 32 90 96 33 84 73 17 141 285 2.009 2.190
2025/2026435 253 153 29 0 0 0 0 0 0 0 0 0
Totale 6.366